Ranbaxy Laboratories hit by 3rd import ban

[Clash]

3rd FDA import ban article:

The U.S. Food and Drug Administration slapped a so-called import alert on the Mohali factory in northern India on Friday, saying the plant owned by India's biggest drugmaker by sales had not met "good manufacturing practices".

The FDA usually issues such alerts banning shipments to the United States after inspectors raise concerns about quality of the medicines produced at facilities.

The FDA action may delay the launch of other new products by Ranbaxy including a generic version of Roche's (ROG.VX) anti-viral Valcyte and AstraZeneca Plc's (AZN.L) blockbuster heartburn and ulcer pill Nexium in the United States, analysts said.

http://in.reuters.com/article/2013/09/16/ranbaxy-fda-alert-idINDEE98F02M20130916

Link to list of Ranbaxy drugs available in US:

http://fortunefeatures.files.wordpress.com/2013/05/ranbaxy-products.pdf

An opinion article related to Ranbaxy:

http://features.blogs.fortune.cnn.com/2013/05/15/ranbaxy-fraud-lipitor/